Introduction
Diabetes is becoming a chronic, global epidemic with accelerated morbidity, increased and earlier mortality, and increased healthcare costs. Total global diabetes prevalence is ∼9.7%, with 92.4 million adults with diabetes [1] . China is one of the countries with the heaviest diabetes burden, and the prevention and control of this disease are difficult tasks for Chinese society. Type 2 diabetes is a progressive and chronic disease characterized by both -cell dysfunction and increased insulin resistance, defined as the inadequate response of skeletal muscle, liver, and adipose tissue to endogenous insulin secretions, and few drugs ameliorate increases in insulin resistance.
Recently, considerable interest has been generated on the extraskeletal and nonclassical effects of vitamin D [2, 3] based on the presence of vitamin D receptors (VDRs) and the activating hydroxylase in target tissues other than bone, gut, and kidney. Animal and human studies suggest that vitamin D may play a role in modulation of the risk of diabetes [4] . Subjects at risk of diabetes had lower 25(OH)D concentrations than those without risk [5, 6] . Vitamin D deficiency was related to the presence and prospective development of type 2 diabetes mellitus [4, [7] [8] [9] [10] [11] , and compared to subjects without diabetes, type 2 diabetes patients had lower serum 25(OH)D [12] . The relationship between vitamin D status and the risk of type 2 diabetes or insulin resistance was reported in several studies. Vitamin D deficiency can play a role in 2 International Journal of Endocrinology insulin resistance and the pathogenesis of type 2 diabetes, through effects on both -cell function and insulin sensitivity [13, 14] . Several roles of vitamin D deficiency are reported affecting insulin resistance through various mechanisms including increasing related proinflammatory cytokines and acute phase reactants, as found in vitamin D deficiency, mediating low-grade inflammation [15] [16] [17] . However, data on the inverse association between 25(OH)D concentrations and the development of insulin resistance (IR) is conflicting. In Europeans with metabolic syndrome, vitamin D status may not correlate with insulin activity or secretion [18] , and relationships between vitamin D status and IR differ among different racial groups. Moreover, little research is available on the association between insulin resistance and vitamin D status in the Chinese population. As a result, this relationship needs to be specifically explored in different populations, including the Chinese. 
Subjects and Methods

Materials and
Anthropometric and Biochemical
Analysis. Data were gathered on age, sex, and family history of type 2 diabetes. Participants' weights and heights were recorded, and body mass index (BMI) was calculated. The body weights and heights were measured while the subjects wore light clothing without shoes. The BMI was calculated as the weight in kilograms divided by the height in meters squared. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured while sitting, after a 5 minute rest, and again after a 10 minute interval, and the mean values were recorded. Hypertension was also diagnosed by a history of hypotensive medication. Blood samples were drawn between 08:00 am and 09:00 am for laboratory analysis of biochemical variables [25-hydroxyvitamin D (25(OH)D), glycated hemoglobin A1c (HbA1c), fasting blood glucose (FBS), fasting insulin (FINS), fasting serum C-peptide, total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL-C), lowdensity lipoprotein (LDL-C), intact parathyroid hormone (iPTH), urea nitrogen (BUN), serum creatinine (SCr), serum calcium (Ca), and serum phosphorus (P)]. Intact parathyroid hormone (iPTH) (ntact parathyroid hormone kits, Beckman Coulter; Beckman DXI800 access immunoassay system), FINS [insulin kits, Roche Diagnostics (Shanghai); Roche Cobas 6000 analyzer], C-peptide (C-peptide kits, Roche Diagnostics; Roche Cobas 6000 analyzer), and serum 25(OH)D (25-hydroxyvitamin D kits, Roche Diagnostics; Roche Cobas 6000 analyzer) concentrations were determined by the electrochemical luminescence method. Fasting blood glucose (blood glucose kits, Beijing Leadman; Beckman DXI800 access immunoassay system) was measured by the oxygen electrode method. Serum creatinine (creatinine kits, Beijing Leadman Biochemistry; Siemens ADVIA 2400 automatic biochemical analyzer), TC (total cholesterol kits, Beijing Leadman Biochemistry; Siemens ADVIA 2400 automatic biochemical analyzer), TG (triglyceride kits, Beijing Leadman Biochemistry; Siemens ADVIA 2400 automatic biochemical analyzer), LDL (low-density lipoprotein kits, Sekisui Medical Japan; Siemens ADVIA 2400 automatic biochemical analyzer), and HDL (high-density lipoprotein kits, Randox UK; Siemens ADVIA 2400 automatic biochemical analyzer) were measured by the enzymatic method. HbA1c (D-10 glycosylated hemoglobin kits, Bio-Rad; Bio-Rad Dias TAT glycosylated hemoglobin analyzer) was measured by High Performance Liquid Chromatography (HPLC). BUN (urea nitrogen kits, Ningbo Medical System; Siemens ADVIA 2400 automatic biochemical analyzer) was measured by the urease method. Serum calcium (calcium kits, Ningbo Medical System; Siemens ADVIA 2400 automatic biochemical analyzer) and serum phosphorus (phosphorus kits, Siemens China; Siemens ADVIA 2400 automatic biochemical analyzer) were measured by the ion selective electrode method. [20] . HOMA-IR was calculated from fasting insulin and fasting glucose. HOMA-IR had the formula fasting glucose (mmol/L) × fasting insulin (pmol/L)/22.5 [23] . eGFR was calculated by the MDRD GFR equation [24] . As this was a retrospective study, and the data were anonymously analysed, informed consent was unnecessary.
2.3.
Statistics. SPSS 19.0 software was used for statistical analysis. Continuous variables were expressed as the mean ± SD (mean standard deviation). Least-Significant Difference test (LSD-) was used to analyse the comparison of 25(OH)D 
Results
Baseline Characteristics.
A total of 117 patients were enrolled in this study; three of them refused 25(OH)D concentration and iPTH test. Table 1 shows the characteristics of the study subjects and their metabolic index levels. The population had an even sex distribution (53.85% male) and a normal BMI (mean BMI = 24.90 ± 3.24 kg/m 2 ) and was middle aged (mean age = 50.38 ± 13.47 years). The results of the analyses comparing data for G1, G2, and G3 are given for the mean ± SD in Table 2 ; the mean HOMA-IR was significantly different between all the three groups, as shown in Table 2 , and both HOMA-IR and fasting insulin values were lower with higher mean 25(OH)D concentrations.
Comparison of G1, G2, and G3 of HOMA-IR and Glucose Metabolism Indices (FINS, HbA1c
Comparison of Male and Female of 25(OH)D, Glucose Metabolism Indices (FBS, FINS, and HbA1c), and HOMA-IR.
The values for serum 25(OH)D and for insulin resistance and glucose indices (fasting blood glucose, fasting insulin levels, and HbA1c) by gender are presented in Table 3 . 25(OH)D values, HOMA-IR, fasting blood glucose, and fasting insulin levels were not significantly different in male and female subjects, but the mean HbA1c was significantly higher in men than that in women, as shown. Table 4 ), vitamin D status was a predictor of HOMA-IR, as the dependent variable, but not eGFR, BMI or age, as independent variables. The Pearson correlation coefficient showed that 25(OH)D had a negative correlation with HOMA-IR (regression coefficient = −0.327, = 0.000; see Figure 1 ).
Relationship between Serum 25(OH)D Levels and HOMA-IR. In the multiple linear regression analysis (shown in
Discussion
The prevalence of type 2 diabetes mellitus (T2DM) has increased significantly and globally over the last few decades. Type 2 diabetes results from insulin resistance linked to dyslipidemia, hyperglycemia, obesity, and hypertension. Few drugs are clinically effective in ameliorating insulin resistance. Vitamin D is a well-known vitamin responsible for bone and calcium metabolism [7] . Its deficiency results in rickets in children and osteomalacia in adults. Cutaneous synthesis and dietary ingestion are the main sources of vitamin D [25, 26] . The proportion of serum vitamin D intake from the diet is small [27, 28] , and it is mainly provided by sun exposure during outdoor activities. In recent years, the extraskeletal effects of vitamin D have attracted much interest [2, 3] . Lower serum 25(OH)D concentrations are associated with higher risks for the development of type 2 diabetes mellitus [8] . In addition, more type 2 diabetes patients than control subjects had vitamin D insufficiency and deficiency [29, 30] [38] . Another study suggested that 25(OH)D possibly modulated glycemic responses, both in impaired glycemia and in healthy subjects [39] . Other studies have indicated a role for vitamin D supplementation in modulation of insulin resistance and improvement of its resultant complications. In Von Hurst et al., insulin resistance was reduced but only if serum 25(OH)D on supplementation reached >80 nmol/L (>32 ng/mL) [40] ; and although few data demonstrated that vitamin D insufficiency was associated with insulin resistance [21, [41] [42] [43] , it was suggested that adequate vitamin D status may be helpful for prevention of increases in insulin resistance and of subsequent T2DM.
The role of vitamin D deficiency in insulin resistance is thought to have several potential mechanisms, including increasing the formation of proinflammatory cytokines and acute phase reactants, likely to increase low-grade inflammation, as well as the well-known promotion of insulin secretion from beta-cells [14, 15, 17] . The efficacy of vitamin D in stimulating insulin release can be affected by vitamin D axis gene polymorphisms, such as those for the activating enzyme (vitamin D 1 -hydroxylase; CYP27B1) and the transport protein (vitamin D binding protein), as well as for vitamin D receptors (VDR) [44] [45] [46] [47] [48] [49] . Moreover, hypocalcemia worsens effects of vitamin D deficiency, including decreasing further the glucose-stimulated release of insulin from -cells [50] . Lower serum 25(OH)D concentrations also increase serum parathyroid hormone (PTH), itself leading to decreased glucose uptake by liver, muscle, and adipose cells [51] . In another study, variants of the vitamin D receptors (VDRs) in pancreatic -cells, skeletal muscle, and adipose tissue were associated with variation in the effects of vitamin D on glucose metabolism. Insulin sensitivity was affected by the presence of 1 -hydroxylase in -cells and the presence of vitamin D response element in the human insulin receptor gene promoter region. The transcription of peroxisome proliferator activator receptor (PPAR) and of the human insulin receptor gene was directly activated by calcitriol; in vitro, vitamin D acceleration of glucose transport was mediated by insulin and vitamin D activated insulin receptor gene transcription [52] [53] [54] [55] . Certain vitamin D binding proteins and allelic variations in the vitamin D receptor gene might also affect insulin secretion and glucose tolerance, which, in turn, might contribute to the genetic risk of type 2 diabetes [56] . Data on the MRC-Ely prospective study demonstrated that the baseline 25(OH)D concentration was inversely related to insulin sensitivity and glycemia [57, 58] . Further research is needed to explore whether vitamin D deficiency results in insulin resistance and whether supplementing with vitamin D or its active metabolite may prevent, or ameliorate, insulin resistance in healthy people or in Chinese people with type 2 diabetes.
Conclusion
Vitamin D status possibly plays a role in maintaining glucose homeostasis. There is a negative correlation between circulating levels of 25(OH)D and insulin resistance in Chinese people with type 2 diabetes.
